You just read:

Novoteris, LLC Receives FDA and Health Canada Clearance to Start a Phase 2 Clinical Trial of Its Thiolanox® Nitric Oxide for the Treatment of Cystic Fibrosis

News provided by

Novoteris, LLC

Jun 05, 2017, 08:40 ET